Bendifallah S, Werkoff G, Borie-Moutafoff C, Antoine M, Chopier J, Gligorov J, Uzan S, Coutant C, Rouzier R (2010) Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications. Surg Oncol 19(4):e115-123. https://doi.org/10.1016/j.suronc.2010.06.001
Lynch SP, Lei X, Chavez-MacGregor M, Hsu L, Meric-Bernstam F, Buchholz TA, Zhang A, Hortobagyi GN, Valero V, Gonzalez-Angulo AM (2012) Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol 23(12):3063–3069. https://doi.org/10.1093/annonc/mds136
Article CAS PubMed PubMed Central Google Scholar
Jain S, Rezo A, Shadbolt B, Dahlstrom JE (2009) Synchronous multiple ipsilateral breast cancers: implications for patient management. Pathology 41(1):57–67. https://doi.org/10.1080/00313020802563502
Yerushalmi R, Kennecke H, Woods R, Olivotto IA, Speers C, Gelmon KA (2009) Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat 117(2):365–370. https://doi.org/10.1007/s10549-008-0265-1
Article CAS PubMed Google Scholar
Neri A, Marrelli D, Megha T, Bettarini F, Tacchini D, De Franco L, Roviello F (2015) Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases. BMC Surg 15:1. https://doi.org/10.1186/1471-2482-15-1
Article PubMed PubMed Central Google Scholar
Wolters R, Wockel A, Janni W, Novopashenny I, Ebner F, Kreienberg R, Wischnewsky M, Schwentner L, Group BS (2013) Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat 142(3):579–590. https://doi.org/10.1007/s10549-013-2772-y
Article CAS PubMed Google Scholar
Lynch SP, Lei X, Hsu L, Meric-Bernstam F, Buchholz TA, Zhang H, Hortobagyi GN, Gonzalez-Angulo AM, Valero V (2013) Breast cancer multifocality and multicentricity and locoregional recurrence. Oncologist 18(11):1167–1173. https://doi.org/10.1634/theoncologist.2013-0167
Article PubMed PubMed Central Google Scholar
Egan RL (1982) Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 49(6):1123–1130. https://doi.org/10.1002/1097-0142(19820315)49:6%3c1123::aid-cncr2820490610%3e3.0.co;2-r
Article CAS PubMed Google Scholar
Tan MP, Sitoh NY, Sitoh YY (2016) Optimising breast conservation treatment for multifocal and multicentric breast cancer: a worthwhile endeavour? World J Surg 40(2):315–322. https://doi.org/10.1007/s00268-015-3336-6
Kanumuri P, Hayse B, Killelea BK, Chagpar AB, Horowitz NR, Lannin DR (2015) Characteristics of multifocal and multicentric breast cancers. Ann Surg Oncol 22(8):2475–2482. https://doi.org/10.1245/s10434-015-4430-6
Houvenaeghel G, Tallet A, Jalaguier-Coudray A, Cohen M, Bannier M, Jauffret-Fara C, Lambaudie E (2016) Is breast conservative surgery a reasonable option in multifocal or multicentric tumors? World J Clin Oncol 7(2):234–242. https://doi.org/10.5306/wjco.v7.i2.234
Article PubMed PubMed Central Google Scholar
Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Spitalier JM (1990) Breast-conserving therapy for macroscopically multiple cancers. Ann Surg 212(1):38–44. https://doi.org/10.1097/00000658-199007000-00006
Article CAS PubMed PubMed Central Google Scholar
Wilson LD, Beinfield M, McKhann CF, Haffty BG (1993) Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancers. Cancer 72(1):137–142. https://doi.org/10.1002/1097-0142(19930701)72:1%3c137::aid-cncr2820720126%3e3.0.co;2-e
Article CAS PubMed Google Scholar
Chung AP, Huynh K, Kidner T, Mirzadehgan P, Sim MS, Giuliano AE (2012) Comparison of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancer. J Am Coll Surg 215(1):137–146; discussion 146–137. https://doi.org/10.1016/j.jamcollsurg.2012.05.006.
Gentilini O, Botteri E, Rotmensz N, Da Lima L, Caliskan M, Garcia-Etienne CA, Sosnovskikh I, Intra M, Mazzarol G, Musmeci S et al (2009) Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat 113(3):577–583. https://doi.org/10.1007/s10549-008-9959-7
Okumura S, Mitsumori M, Yamauchi C, Kawamura S, Oya N, Nagata Y, Hiraoka M, Kokubo M, Mise K, Kodama H (2004) Feasibility of breast-conserving therapy for macroscopically multiple ipsilateral breast cancer. Int J Radiat Oncol Biol Phys 59(1):146–151. https://doi.org/10.1016/j.ijrobp.2003.09.088
Lim W, Park EH, Choi SL, Seo JY, Kim HJ, Chang MA, Ku BK, Son B, Ahn SH (2009) Breast conserving surgery for multifocal breast cancer. Ann Surg 249(1):87–90. https://doi.org/10.1097/SLA.0b013e31818e41c0
Oh JL, Dryden MJ, Woodward WA, Yu TK, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH et al (2006) Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol 24(31):4971–4975. https://doi.org/10.1200/JCO.2006.07.6067
Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee KJ, Haffty B et al (2018) The feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: an initial report from ACOSOG Z11102 (Alliance) Trial. Ann Surg Oncol 25(10):2858–2866. https://doi.org/10.1245/s10434-018-6583-6
Ataseven B, Lederer B, Blohmer JU, Denkert C, Gerber B, Heil J, Kuhn T, Kummel S, Rezai M, Loibl S et al (2015) Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol 22(4):1118–1127. https://doi.org/10.1245/s10434-014-4122-7
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416. https://doi.org/10.1001/jama.2017.7112
Article CAS PubMed Google Scholar
Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812–822. https://doi.org/10.1093/jnci/djt095
Article CAS PubMed Google Scholar
McCrorie AD, Ashfield S, Begley A, McIlmunn C, Morrison PJ, Boyd C, Eccles B, Greville-Heygate S, Copson ER, Cutress RI et al (2020) Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers. J Pathol Clin Res 6(2):146–153. https://doi.org/10.1002/cjp2.155
Article CAS PubMed PubMed Central Google Scholar
Sun J, Meng H, Yao L, Lv M, Bai J, Zhang J, Wang L, Ouyang T, Li J, Wang T et al (2017) Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res 23(20):6113–6119. https://doi.org/10.1158/1078-0432.CCR-16-3227
Article CAS PubMed Google Scholar
Zhang J, Sun J, Chen J, Yao L, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B et al (2016) Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer. Breast Cancer Res Treat 158(3):455–462. https://doi.org/10.1007/s10549-016-3902-0
Article CAS PubMed Google Scholar
Su L, Zhang J, Meng H, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y (2018) Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer. Clin Genet 94(1):165–169. https://doi.org/10.1111/cge.13256
Article CAS PubMed Google Scholar
Fushimi A, Yoshida A, Yagata H, Takahashi O, Hayashi N, Suzuki K, Tsunoda H, Nakamura S, Yamauchi H (2019) Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancer. Surg Today 49(3):224–230. https://doi.org/10.1007/s00595-018-1725-9
Weissenbacher TM, Zschage M, Janni W, Jeschke U, Dimpfl T, Mayr D, Rack B, Schindlbeck C, Friese K, Dian D (2010) Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat 122(1):27–34. https://doi.org/10.1007/s10549-010-0917-9
Article CAS PubMed Google Scholar
Haffty BG, Harrold E, Khan AJ, Pathare P, Smith TE, Turner BC, Glazer PM, Ward B, Carter D, Matloff E et al (2002) Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 359(9316):1471–1477. https://doi.org/10.1016/S0140-6736(02)08434-9
Garcia-Etienne CA, Barile M, Gentilini OD, Botteri E, Rotmensz N, Sagona A, Farante G, Galimberti V, Luini A, Veronesi P et al (2009) Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? Ann Surg Oncol 16(12):3380–3387. https://doi.org/10.1245/s10434-009-0638-7
留言 (0)